Cerebriu is a Copenhagen-based radiology AI company focused on automating MRI workflows. Its flagship product, Apollo, is described as the first CE-marked real-time MRI triage and automated protocol optimization solution for brain MRI, helping ensure the right images are captured during a scan and prioritizing urgent cases.
By automating protocol decisions and triage in real time, Cerebriu addresses one of radiology's biggest pressures: chronic staffing shortages and growing imaging volumes. The technology aims to reduce repeat scans, speed time-to-diagnosis, and improve consistency across imaging sites.
Cerebriu has been deployed in hospitals across Europe, Asia, and the Middle East. In its Series A, the company raised €17.4M (about $19M) led by Danish VC firm North Ventures, with continued support from EIFO (Denmark's Export and Investment Fund) and Sagitta Ventures. The funding is being used to broaden its product portfolio and accelerate commercial expansion.
Founded in 2018, Cerebriu represents the European wave of clinical imaging-AI companies targeting workflow automation rather than standalone detection, embedding intelligence directly into the MRI acquisition process.